Log in to save to my catalogue

Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension

Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6ca03ee34a4e496ca26a6aba6d9e3633

Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension

About this item

Full title

Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension

Publisher

England: BioMed Central Ltd

Journal title

Respiratory research, 2024-06, Vol.25 (1), p.235-11, Article 235

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Abnormal remodeling of distal pulmonary arteries in patients with pulmonary arterial hypertension (PAH) leads to progressively increased pulmonary vascular resistance, followed by right ventricular hypertrophy and failure. Despite considerable advancements in PAH treatment prognosis remains poor. We aim to evaluate the potential for using the cytok...

Alternative Titles

Full title

Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6ca03ee34a4e496ca26a6aba6d9e3633

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6ca03ee34a4e496ca26a6aba6d9e3633

Other Identifiers

ISSN

1465-993X,1465-9921

E-ISSN

1465-993X

DOI

10.1186/s12931-024-02861-8

How to access this item